66 related articles for article (PubMed ID: 25505565)
1. Regulation of circulating endocannabinoids associated with cancer and metastases in mice and humans.
Sailler S; Schmitz K; Jäger E; Ferreiros N; Wicker S; Zschiebsch K; Pickert G; Geisslinger G; Walter C; Tegeder I; Lötsch J
Oncoscience; 2014; 1(4):272-282. PubMed ID: 25594019
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms.
Mukhopadhyay B; Schuebel K; Mukhopadhyay P; Cinar R; Godlewski G; Xiong K; Mackie K; Lizak M; Yuan Q; Goldman D; Kunos G
Hepatology; 2015 May; 61(5):1615-26. PubMed ID: 25580584
[TBL] [Abstract][Full Text] [Related]
3. XCHD Inhibits C6 Cell Growth Primarily via the p53/Caspase Pathway.
Yu H; Sun Q; Yun F; Xu X; Ding F; Li S; Zhao P
Evid Based Complement Alternat Med; 2020; 2020():7973639. PubMed ID: 33029173
[TBL] [Abstract][Full Text] [Related]
4. Classification of clear cell renal cell carcinoma based on
Li X; Turanli B; Juszczak K; Kim W; Arif M; Sato Y; Ogawa S; Turkez H; Nielsen J; Boren J; Uhlen M; Zhang C; Mardinoglu A
Heliyon; 2020 Feb; 6(2):e03440. PubMed ID: 32095654
[TBL] [Abstract][Full Text] [Related]
5. Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Singh NS; Bernier M; Wainer IW
Pharmacol Res; 2016 Sep; 111():757-766. PubMed ID: 27423937
[TBL] [Abstract][Full Text] [Related]
6. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
8. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β
Wnorowski A; Dudzik D; Bernier M; Wójcik J; Keijzers G; Diaz-Ruiz A; Mazur K; Zhang Y; Han H; Scheibye-Knudsen M; Jozwiak K; Barbas C; Wainer IW
Sci Rep; 2022 Mar; 12(1):3618. PubMed ID: 35256673
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse.
Bernier M; Paul RK; Dossou KS; Wnorowski A; Ramamoorthy A; Paris A; Moaddel R; Cloix JF; Wainer IW
Pharmacol Res Perspect; 2013 Dec; 1(2):e00010. PubMed ID: 25505565
[TBL] [Abstract][Full Text] [Related]
10. Concurrent activation of β
Wnorowski A; Such J; Paul RK; Wersto RP; Indig FE; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2017 Aug; 36():176-188. PubMed ID: 28495590
[TBL] [Abstract][Full Text] [Related]
11. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
